$1401.4m market cap
$1.02 last close
BioPharma Credit was incorporated in October 2016 in the UK and aims at generating predictable income for shareholders over the long term through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. This includes senior secured notes, royalty debt instruments and priority royalty tranches. BPCR may also invest in unsecured debt (up to 35% of gross assets) as well as credit-linked notes. It can also have an equity exposure of up to 15% of gross assets.
Investment summary
BioPharma Credit (BPCR) recently announced that it has entered into an agreement to provide a US$80m senior secured loan to BioDelivery Sciences International (BDSI), a Nasdaq-listed commercial-stage pharma company. BDSI’s main assets include Belbuca, an FDA-approved partial opioid agonist classified as a Schedule III drug, as well as Symproic, an FDA-approved drug for the treatment of opioid-induced constipation (OIC). This agreement represents BPCR’s first investment this year. Moreover, it invested US$25m in BDSI’s recent share issue, which constitutes BPCR’s first equity investment since inception. We estimate that BPCR still has around US$500m in uncommitted cash available for further deals.
Sector |
|---|
| Investment companies |
Share price graph
Price performance
% |
1m |
3m |
12m |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
| *% relative to local index | |||||||||||||||
Key management |
|
|---|---|
| Alexander Perfall | VP, Investor Relations & Public Affairs |
You may also be interested in…
- Aberdeen Asian Income Fund
- Aberdeen Diversified Income and Growth Trust
- Aberdeen New Thai Investment Trust
- Aberdeen Standard Equity Income Trust
- Acorn Income Fund
- Atlantis Japan Growth Fund
- Baker Steel Resources Trust
- Bankers Investment Trust (The)
- BlackRock Emerging Europe
- BlackRock Greater Europe Investment Trust
- BlackRock Latin American Inv. Trust
- BMO Managed Portfolio Trust Growth Portfolio
- BMO Managed Portfolio Trust Income Portfolio
- Canadian General Investments
- CVC Credit Partners European Opps
- Diverse Income Trust (The)
- EJF Investments
- European Assets Trust
- F&C Investment Trust
- Fidelity Asian Values
- Fidelity China Special Situations
- Fidelity European Values
- Fidelity Japan Trust
- Fidelity Special Values
- Finsbury Growth & Income Trust
- Genesis Emerging Markets Fund
- Gulf Investment Fund
- Hansa Trust
- HarbourVest Global Private Equity
- Henderson Alternative Strategies Trust
- Henderson Far East Income
- Henderson International Income Trust
- HgCapital Trust
- Invesco Asia Trust
- JPMorgan Global Convertibles Income Fund
- JPMorgan Global Growth & Income
- Jupiter Green Investment Trust
- Jupiter UK Growth Investment Trust
- Jupiter US Smaller Companies
- Lazard World Trust Fund
- Lowland Investment Company
- Marble Point Loan Financing
- Martin Currie Asia Unconstrained Trust
- Martin Currie Global Portfolio Trust
- Murray Income Trust
- Murray International Trust
- Ocean Wilsons Holdings
- Princess Private Equity Holding
- Schroder AsiaPacific Fund
- ScotGems
- Scottish Oriental Smaller Companies
- Securities Trust of Scotland
- Seneca Global Income & Growth Trust
- Standard Life Investments Property Income Trust
- Standard Life Private Equity Trust
- Standard Life UK Smaller Companies
- Templeton Emerging Markets Investment Trust
- The Biotech Growth Trust
- The Brunner Investment Trust
- The European Investment Trust
- The Law Debenture Corporation
- The Merchants Trust
- The North American Income Trust
- The Scottish Investment Trust
- TR European Growth Trust
- UK Commercial Property REIT
- Utilico Emerging Markets Trust
- Vietnam Enterprise Investments
- VinaCapital Vietnam Opportunity Fund
- Witan Investment Trust
- Witan Pacific Investment Trust
- Worldwide Healthcare Trust